CVS Health Corp

NYSE:CVS   3:59:59 PM EDT
106.79
+1.93 (+1.84%)
Other Pre-Announcement

CVS Health Updates 2021 Adjusted EPS Guidance To At Least $8, Initiates 2022 Guidance For Adjusted EPS OF $8.10 - $8.30

Published: 12/09/2021 11:42 GMT
CVS Health Corp (CVS) - Cvs Health Presents Strategy for Revolutionizing Consumer Health Experience While Driving Profitable Growth.
Updating 2021 Adjusted EPS Guidance to at Least $8.00.
Initiating 2022 Guidance for Adjusted EPS of $8.10 - $8.30 and GAAP EPS of $7.04 - $7.24.
Returning Capital to Shareholders Through 10% Dividend Raise and $10 Billion Share Repurchase Program.
Advancement of Health Services and Primary Care Capabilities Will Augment Performance in Foundational Businesses.
Sees 2021 Total Revenues: at Least $290.3 Billion.
Sees 2021 GAAP Eps: $5.50 to $5.61.
Sees 2022 Total Revenues: $304.0 to $309.0 Billion.
Will Focus on Priority Areas Including Launching New All-payer Health Products and Services.
FY2021 Earnings per Share View $7.98, Revenue View $288.93 Billion -- Refinitiv Ibes Data (analyst estimates).
FY2022 Earnings per Share View $8.24, Revenue View $301.66 Billion -- Refinitiv Ibes Data (analyst estimates).